Prevalence of HIV and HCV among injecting drug users in three selected WHO-EMRO countries: a meta-analysis.  Shayan, S.J., Nazari, R. & Kiwanuka, F.  Harm Reduct J 18, 59 (2021). doi.org/10.1186/s12954-021-00505-4 https://harmreduct…

CME. Aktuelles Management von Hepatitis C bei Drogenkonsumenten Kurzbeschreibung: Hepatitis C ist eine durch das Hepatitis-C-Virus (HCV) verursachte Leberentzündung mit überwiegend chronischem Verlauf. Die Symptome der chronischen Hepatit…

World Hepatitis Day 2021 With a person dying every 30 seconds from a hepatitis related illness – even in the current COVID-19 crisis – we can’t wait to act on viral hepatitis. People living with viral hepatitis unaware can’t wait for tes…

Identification and treatment of viral hepatitis C in persons who use drugs: a prospective, multicenter outreach study in Flanders, Belgium.  Busschots, D., Kremer, C., Bielen, R. et al.  Harm Reduct J 18, 54 (2021). doi.org/10.1186/s1295…

Reduction in the population prevalence of hepatitis C virus viraemia among people who inject drugs associated with scale‐up of direct‐acting anti‐viral therapy in community drug services: real‐world data.  Palmateer, N. E., McAuley, A., Dillon…

Modeling Combination Hepatitis C Virus Treatment and Prevention Strategies in a Network of People Who Inject Drugs in the United States.  Zelenev A, Li J, Shea P, Hecht R, Altice FL.  Clin Infect Dis. 2021 Mar 1;72(5):755-763. doi: 10.10…